Monoclonal antibody
Identifiers |
---|
CAS Number | |
---|
ChemSpider | |
---|
UNII | |
---|
Chemical and physical data |
---|
Formula | C6400H9934N1702O1996S48 |
---|
Molar mass | 144196.67 g·mol−1 |
Diridavumab (CR6261) (INN[1]) is a monoclonal antibody designed for the treatment of influenza A.[2]
This drug was developed by Janssen Pharmaceutical Companies of Johnson & Johnson.
References
- ^ World Health Organization (2014). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 111" (PDF). WHO Drug Information. 28 (2).
- ^ Statement On A Nonproprietary Name Adopted By The USAN Council - Diridavumab, American Medical Association.